Literature DB >> 33272966

Will Targeting Interleukin-6 in the Anemia of CKD Change Our Treatment Paradigm?

Daniel W Coyne1, Robert Fleming2.   

Abstract

Entities:  

Keywords:  anemia; erythropoietin; hemodialysis

Mesh：

Substances：

Year:  2020        PMID： 33272966      PMCID： PMC7894666          DOI： 10.1681/ASN.2020101476

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  10 in total

1.  KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2006-05       Impact factor: 8.860

2.  Systemic inflammation is associated with exaggerated skeletal muscle protein catabolism in maintenance hemodialysis patients.

Authors:  Serpil M Deger; Adriana M Hung; Jorge L Gamboa; Edward D Siew; Charles D Ellis; Cindy Booker; Feng Sha; Haiming Li; Aihua Bian; Thomas G Stewart; Roy Zent; William E Mitch; Naji N Abumrad; T Alp Ikizler
Journal:  JCI Insight       Date:  2017-11-16

3.  Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus.

Authors:  Sara Gardenghi; Tom M Renaud; Alessandra Meloni; Carla Casu; Bart J Crielaard; Laura M Bystrom; Noa Greenberg-Kushnir; Barbra J Sasu; Keegan S Cooke; Stefano Rivella
Journal:  Blood       Date:  2013-12-19       Impact factor: 22.113

4.  Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.

Authors:  Jayanta Gupta; Nandita Mitra; Peter A Kanetsky; Joe Devaney; Maria R Wing; Muredach Reilly; Vallabh O Shah; Vaidyanathapura S Balakrishnan; Nicolas J Guzman; Matthias Girndt; Brian G Periera; Harold I Feldman; John W Kusek; Marshall M Joffe; Dominic S Raj
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-27       Impact factor: 8.237

Review 5.  Anemia of Inflammation.

Authors:  Tomas Ganz
Journal:  N Engl J Med       Date:  2019-09-19       Impact factor: 91.245

Review 6.  Markers of iron status in chronic kidney disease.

Authors:  Adam E Gaweda
Journal:  Hemodial Int       Date:  2017-03-22       Impact factor: 1.812

7.  Clinical and Economic Outcomes of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Post-Bundling Era.

Authors:  Borut Cizman; Helen T Smith; Rodrigo Refoios Camejo; Linda Casillas; Harjeet Dhillon; Fan Mu; Eric Wu; Jipan Xie; Peter Zuckerman; Daniel Coyne
Journal:  Kidney Med       Date:  2020-08-10

8.  Hyporesponsiveness to erythropoietin therapy in hemodialyzed patients: potential role of prohepcidin, hepcidin, and inflammation.

Authors:  Jolanta Malyszko; Jacek S Malyszko; Michal Mysliwiec
Journal:  Ren Fail       Date:  2009       Impact factor: 2.606

9.  IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.

Authors:  Elizabeta Nemeth; Seth Rivera; Victoria Gabayan; Charlotte Keller; Sarah Taudorf; Bente K Pedersen; Tomas Ganz
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

10.  Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Pablo E Pergola; Matt Devalaraja; Steven Fishbane; Michel Chonchol; Vandana S Mathur; Mark T Smith; Larry Lo; Kurt Herzog; Rahul Kakkar; Michael H Davidson
Journal:  J Am Soc Nephrol       Date:  2020-12-03       Impact factor: 10.121
  10 in total
  2 in total

1.  Association Between the Blood Copper-Zinc (Cu/Zn) Ratio and Anemia in Patients Undergoing Maintenance Hemodialysis.

Authors:  Sujun Zuo; Mengmeng Liu; Yun Liu; Shilin Xu; Xiaoshi Zhong; Jingxian Qiu; Danping Qin; Rongshao Tan; Yan Liu
Journal:  Biol Trace Elem Res       Date:  2021-09-04       Impact factor: 3.738

2.  Chronic Kidney Disease of Unknown Etiology (CKDu) in Sri Lanka: Hematological Changes and Pro-Inflammation Suggest Likely Predictors of Advance Disease, as Renal Outcomes Show Prevalent Normoalbuminuria.

Authors:  S H Nandana P Gunawickrama; K Imesha G Hewavitharana; P G Chandra L Nanayakkara; K B Suneetha Gunawickrama
Journal:  Diseases       Date:  2021-12-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.